OK Biotech Co., Ltd. (TPE:4155)

Market Cap	2.32B
Revenue (ttm)	1.73B
Net Income (ttm)	82.67M
Shares Out	142.06M
EPS (ttm)	0.57
PE Ratio	28.62
Forward PE	n/a
Dividend	0.30 (1.84%)
Ex-Dividend Date	Jul 4, 2025

Volume	57,166
Average Volume	86,291
Open	16.30
Previous Close	16.30
Day's Range	16.00 - 16.30
52-Week Range	13.90 - 27.05
Beta	0.09
RSI	46.46
Earnings Date	Aug 11, 2025

About OK Biotech

OK Biotech Co., Ltd. develops, manufactures, markets, and sells blood glucose monitoring devices and related homecare medical products in Taiwan and internationally. It also provides glucometers and blood glucose test strips; nebulizer, portable nebulizer, mesh nebulizer, and test strips; and personal sound amplifiers. OK Biotech Co., Ltd. was founded in 2006 and is headquartered in Hsinchu City, Taiwan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4155

Financial Performance

In 2024, OK Biotech's revenue was 1.67 billion, an increase of 40.11% compared to the previous year's 1.19 billion. Earnings were 93.98 million, an increase of 3087.75%.